Biomarker Assay Development

Register for this event and receive complimentary access to: Translational Cancer Medicine

Coverage Includes:

• Incorporating assay development into an overall biomarker strategy
• Multiplexed biomarker assays
• Fit-for-purpose assay development
• Total vs. free analyte quantification
• In-house assay development vs. off-the-shelf solutions vs. outsourcing
• Translation from in-house development to clinical laboratory
• Assay development for genomic and proteomic biomarkers
• Circulating cell assays
• Novel detection technologies

Pre-Conference Events:

• Tutorial: Fit-for-Purpose Biomarker Assay Development and Validation
• Workshop: Novel Cancer Biomarkers